Gambia: MRCG Holds Open Day On ETVAX Study On Diarrhoea On Children

MRC-The Gambia London School of Hygiene and Tropical Medicine in collaboration with the government of The Gambia on Wednesday organized an open day forum on ETVAX study project dubbed ‘a vaccine trial study focus on diarrhoea diseases to see the safety and efficacy of the ETEC vaccine.’

The program is aimed at building a stronger partnership between MRCG and London School of Hygiene and Tropical Medicine, the Community and the Government of The Gambia. The event was held in Farafenni in the North Bank Region.

At the forum, AbdolieJarju, regional health director for North Bank East Health Region in Farafenni, thankedMRCG for complementing the efforts of the Ministry of Health in the attainment of quality health care, recalling that the past results demonstrated MRCG’s invaluable support to the health sector.

He equally called on communities and health facilities to closely work as a team to ensure proper health care needs of the population and most importantly children under5 years.

Dr. Jahangir Hossain of MRCG gave an overview of the ETVAX trail project, saying it is aimed at protecting children from disease and improved health of children between 6 and 18 months.

“Diarrhoea contributes to 9% of death among children under 5 years registered in The Gambia. The program was earlier conducted in Upper River and Central River Regions and the rolling up of program. High burden and mortality among children and said the vaccine has been found to be safe and protected and would help to protect children 6 months to 18 months.”